全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

RNAi技术在抗甲型流感病毒中的研究进展

DOI: 10.13560/j.cnki.biotech.bull.1985.2014.12.009, PP. 55-60

Keywords: 流感病毒,RNA,干扰,siRNA,miRNA,复制,疫苗

Full-Text   Cite this paper   Add to My Lib

Abstract:

RNAi技术广泛应用于防治人类多种疾病病原的药物和疫苗开发中,并取得了巨大的成果。流感病毒极易发生抗原漂移和抗原转变,这给抗流感病毒药物和疫苗的研制提出很大的挑战。RNAi技术的出现给流感的防治提供了新的思路。对近年来国内外利用RNAi技术开发抗流感病毒药物和新型流感疫苗研究现状及前景进行综述,以期为流感的综合防治研究提供参考。

References

[1]  Thomas M, Ge Q, Lu JJ, et al. Polycation-mediated delivery of siRNAs for prophylaxis and treatment of influenza virus infection[J]. Expert Opin Biol Ther, 2005, 5(4):495-505.
[2]  Betáková T, Svan?arová P. Role and application of RNA interference in replication of influenza viruses[J]. Acta Virol, 2013, 57(2): 97-104.
[3]  Ge Q, McManus MT, Nguyen T, et al. RNA interference of influenza virus production by directly targeting mRNA for degradation and indirectly inhibiting all viral RNA transcription[J]. Proc Natl Acad Sci USA, 2003, 100(5):2718-2723.
[4]  Raza A, Shareef H, Salim H, et al. Selection of predicted siRNA as potential antiviral therapeutic agent against influenza virus[J]. Bioinformation, 2011, 6(9):340-343.
[5]  ElHefnawi M, Hassan N, Kamar M, et al. The design of optimal therapeutic small interfering RNA molecules targeting diverse strains of influenza A virus[J]. Bioinformatics, 2011, 27(24):3364-3370.
[6]  Perez JT, Varble A, Sachidanandam R, et al. Influenza A virus-generated small RNAs regulate the switch from transcription to replication[J]. Proc Natl Acad Sci USA, 2010, 107(25): 11525-11530.
[7]  Umbach JL, Yen HL, Poon LL, et al. Influenza A virus expresses high levels of an unusual class of small viral leader RNAs in infected cells[J]. MBio, 2010, 1(4):e00204-e00210.
[8]  K?nig R, Stertz S, Zhou Y, et al. Human host factors required for influenza virus replication[J]. Nature, 2010, 463(7282): 813-817.
[9]  Hirsch AJ. The use of RNAi-based screens to identify host proteins involved in viral replication[J]. Future Microbiol, 2010, 5(2): 303-311.
[10]  Buggele WA, Johnson KE, Horvath CM. Influenza A virus infection of human respiratory cells induces primary microRNA expression[J]. J Biol Chem, 2012, 287(37):31027-31040.
[11]  Lam WY, Yeung AC, Ngai KL, et al. Effect of avian influenza A H5-N1 infection on the expression of microRNA-141 in human respira-tory epithelial cells[J]. BMC Microbiology, 2013, 13: 104.
[12]  Ma YJ, Yang J, Fan XL, et al. Cellular microRNA let-7c inhibits M1 protein expression of the H1N1 influenza A virus in infected human lung epithelial cells[J]. J Cell Mol Med, 2012, 16(10): 2539-2546.
[13]  Song H, Wang Q, Guo Y, et al. Microarray analysis of microRNA expression in peripheral blood mononuclear cells of critically ill patients with influenza A(H1N1)[J]. BMC Infect Dis, 2013, 13: 257.
[14]  Loveday EK, Svinti V, Diederich S, et al. Temporal-and strain-specific host microRNA molecular signatures associated with swine-origin H1N1 and avian-origin H7N7 influenza A virus infection[J]. J Virol, 2012, 86(11):6109-6122.
[15]  Hamamoto I, Takaku H, Tashiro M, et al. High yield production of influenza virus in madin darby canine kidney(MDCK)cells with stable knockdown of IRF7[J]. PLoS One, 2013, 8(3):e59892.
[16]  Kelly EJ, Russell SJ. MicroRNAs and the regulation of vector tropism[J]. Mol Ther, 2009, 17(3):409-416.
[17]  张国海, 王启钊, 张景红, 等. microRNA 调控的靶向性病毒载 体在基因治疗中的应用[J]. 生物工程进展, 2010, 26(6): 707-714.
[18]  Varble A, Chua MA, Perez JT, et al. Engineered RNA viral synthesis of micro RNAs[J]. Proc Natl Acad Sci USA, 2010, 107 (25):11519-11524.
[19]  Barik S. New treatments for influenza[J]. BMC Medicine, 2012, 10: 104.
[20]  田 进, 张在 平, 孟 庆 文, 等. 表 达 靶 向 禽 流 感 病 毒 多 靶 点 miRNA 重组慢病毒的制备及病毒感染效率检测[J]. 中国兽 医学报, 2010, 30(5):583-587.
[21]  刘文博, 张小荣, 曹永忠, 等. 表达禽流感病毒特异性 siRNA 分子减毒鼠伤寒沙门氏菌的构建[J]. 病毒学报, 2007, 23(2): 125-129.
[22]  Knossow M, Skehel JJ. Variation and infectivity neutralization in influenza[J]. Immunology, 2006, 119(1):1-7.
[23]  杨 帅, 朱 闻 斐, 舒 跃 龙. 猪 流 感病 毒 概 述[J]. 病 毒学 报. 2013, 29(3):330-336.
[24]  张宏伟. H7N9 禽流感的病毒特征及其对人类健康的潜在威 胁[J]. 第二军医大学学报, 2013, 34(6):591-594.
[25]  张宝, 黄克勇, 郭劲松, 等. H7N9 病毒的来源和重组模式[J]. 南方医科大学学报, 2013, 33(7):1017-1021.
[26]  ElHefnawi M, Alaidi O, Mohamed N, et al. Identification of novel conserved functional motifs across most influenza A viral strains[J]. Virol J, 2011, 8: 44.
[27]  Perez JT, Zlatev I, Aggarwal S, et al. A small-RNA enhancer of viral polymerase activity[J]. J Virol, 2012, 86(24):13475-13485.
[28]  Meliopoulos VA, Andersen LE, Birrer KF, et al. Host gene targets for novel influenza therapies elucidated by high-throughput RNA interference screens[J]. FASEB J, 2012, 26(4):1372-1386.
[29]  DeVincenzo JP. The promise, pitfalls and progress of RNA-interference-based antiviral therapy for respiratory viruses[J]. Antivir Ther, 2012, 17(1 Pt B):213-225.
[30]  Karlas A, Machuy N, Shin Y, et al. Genome-wide RNAi screen identifies human host factors crucial for influenza virus replication[J]. Nature, 2010, 463(7282):818-822.
[31]  张传军, 连海. miRNA 调控病毒与宿主细胞相互作用的研究进展[J]. 中国生物制品学杂志, 2010, 23(5):549-553.
[32]  Guan Z, Shi N, Song Y, et al. Induction of the cellular microRNA-29c by influenza virus contributes to virus-mediated apoptosis through repression of antiapoptotic factors BCL2L2[J]. Biochem Biophys Res Commun, 2012, 425(3):662-667.
[33]  Song L, Liu H, Gao S, et al. Cellular microRNAs inhibit replication of the H1N1 influenza A virus in infected cells[J]. J Virol, 2010, 84(17):8849-8860.
[34]  Wang Y, Brahmakshatriya V, Lupiani B, et al. Integrated analysis of microRNA expression and mRNA transcriptome in lungs of avian influenza virus infected broilers[J]. BMC Genomics, 2012, 13: 278.
[35]  范鸣. Alnylam 公司与葛兰素史克公司合作应用 VaxiRNA 技术提高疫苗生产能力[J]. 药学进展, 2012, 36(5):230.
[36]  Nilsen TW. Mechanisms of microRNA-mediated gene regulation in animal cells[J]. Trends Genet, 2007, 23(5):243-249.
[37]  Perez JT, Pham AM, Lorini MH, et al. MicroRNA-mediated species-specific attenuation of influenza A virus[J]. Nat Biotechnol, 2009, 27(6):572-576.
[38]  Barik S. siRNA for influenza therapy[J]. Viruses, 2010, 2: 1448-1457.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133